The Healthcare ETF that could be hit by Trade Wars
The healthcare sector is usually viewed as defensive and derives significant portions of revenue from within the U.S., making the group an ideal sector for investors looking to avoid the […]
The healthcare sector is usually viewed as defensive and derives significant portions of revenue from within the U.S., making the group an ideal sector for investors looking to avoid the […]
Doctor knows best, can now be applied to investing. That’s the idea behind RedCrow, an alternative investment platform out of Mill Valley, California that provides investors with access to doctor-vetted […]
A scientist has warned AI will eventually make doctors ‘obsolete’. Artificial intelligence has a ‘near unlimited capacity’ to diagnose diseases and perform surgery more accurately than medics, according to Dr […]
If recent research is any indication, artificial intelligence (AI) has a bright future in medicine. Nvidia developed an AI system that can generate synthetic scans of brain cancer. Google subsidiary […]
MIT researchers are employing novel machine-learning techniques to improve the quality of life for patients by reducing toxic chemotherapy and radiotherapy dosing for glioblastoma, the most aggressive form of brain […]
In September 2017, I wrote an article about the STOXX 600 Supersector Europe Health Care Index, pointing out that there were technical signs of a delicate but constructive situation. I […]
Amazon, JP Morgan Chase, and Berkshire Hathaway announced today they are forming a non-profit joint venture to manage and streamline their employee healthcare programs.
The CEOs of these giant companies — Jeff Bezos of Amazon, Jamie Dimon of Chase, and Warren Buffet of Berkshire Hathaway — say the new company will focus on technology solutions that will provide high-quality health benefits at a reasonable cost.
The aim of the test, CancerSEEK is called, is to catch the disease early and save lives. In a study Thursday in the journal Science, Johns Hopkins University scientists looked to see how well their experimental test detected cancer in people already known to have the disease. The blood tests found about 70 percent of eight common types of cancer in the 1,005 patients. The rates varied depending on the type – lower for breast tumors but high for ovarian, liver and pancreatic ones.